Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Spencer

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
The Lancet. Public Health|May 3, 2024
Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021Vedavati Patwardhan, Gabriela F Gil, Alejandra Arrieta, et al.
Cell|March 11, 2026
Microbiome-produced nicotinic acid controls colon regional identity and injury susceptibilityJérémie Rispal, Jasmine R Garcia, Brisa Palikuqi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 16, 2025
Author ReplyAdam Brook, Georgia Baynes, Jonathan Scargill, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 19, 2025
Free Foetal Haemoglobin in Severe Early-Onset Foetal Growth Restriction: A Prospective Multi-Centre StudyAdam Brook, Georgia Baynes, Jonathan Scargill, et al.
Cancer Cell|April 10, 2023
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanomaKatie M Campbell, Meelad Amouzgar, Shannon M Pfeiffer, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 24, 2025
Economic Impact of Severe Early-Onset Foetal Growth Restriction: A Multicentre Prospective Cohort StudyGeorge Bray, Kasia Maksym, Maurvi Dilipkumar, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort studyZoe Quandt, Anastasia Lucas, Samantha I Liang, et al.
Prenatal Diagnosis|September 22, 2021
Development of standard definitions and grading for Maternal and Fetal Adverse Event TerminologyRebecca N Spencer, Kurt Hecher, Gill Norman, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Lancet (London, England)|March 5, 2022
Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021Luisa S Flor, Joseph Friedman, Cory N Spencer, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
The Lancet. Public Health|May 3, 2024
Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021Vedavati Patwardhan, Gabriela F Gil, Alejandra Arrieta, et al.
Cell|March 11, 2026
Microbiome-produced nicotinic acid controls colon regional identity and injury susceptibilityJérémie Rispal, Jasmine R Garcia, Brisa Palikuqi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 16, 2025
Author ReplyAdam Brook, Georgia Baynes, Jonathan Scargill, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 19, 2025
Free Foetal Haemoglobin in Severe Early-Onset Foetal Growth Restriction: A Prospective Multi-Centre StudyAdam Brook, Georgia Baynes, Jonathan Scargill, et al.
Cancer Cell|April 10, 2023
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanomaKatie M Campbell, Meelad Amouzgar, Shannon M Pfeiffer, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 24, 2025
Economic Impact of Severe Early-Onset Foetal Growth Restriction: A Multicentre Prospective Cohort StudyGeorge Bray, Kasia Maksym, Maurvi Dilipkumar, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort studyZoe Quandt, Anastasia Lucas, Samantha I Liang, et al.
Prenatal Diagnosis|September 22, 2021
Development of standard definitions and grading for Maternal and Fetal Adverse Event TerminologyRebecca N Spencer, Kurt Hecher, Gill Norman, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Lancet (London, England)|March 5, 2022
Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021Luisa S Flor, Joseph Friedman, Cory N Spencer, et al.
Pageof 21